Evofem Holdings, Inc. Announces Successful Completion of Pre-IND Meeting for Amphora SAN DIEGO, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Evofem, a biotechnology company focused on the development and commercialization of women's health products, announced today that it met with...

Evofem, Inc. Announces FDA Acceptance of New Drug Application for Amphora(TM) as a Contraceptive SAN DIEGO, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Evofem, Inc. today announced that a New Drug Application for Amphora has been accepted for filing by the United States Food and Drug Administration (FDA)....